Laman Utama › Majikan › Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc.: Gaji H-1B dan penajaan
Neurocrine Biosciences, Inc. memfailkan 48 permohonan syarat buruh untuk visa H-1B dan berkaitan dalam tahun fiskal 2023–2026; disahkan: 47. Gaji median yang ditawarkan: $121,722.
Adakah Neurocrine Biosciences, Inc. menaja visa H-1B?
Neurocrine Biosciences, Inc. memfailkan 48 permohonan syarat buruh dalam tahun fiskal 2023–2026, yang terkini dihantar pada 17 Jun 2026. LCA adalah langkah pertama dalam petisyen H-1B, jadi majikan telah menaja atau bersedia untuk menaja pekerja H-1B; ia tidak menjamin penajaan untuk mana-mana jawatan tertentu. Semak senarai pekerjaan majikan itu sendiri.
Gaji mengikut jawatan
| Jawatan | LCA | Gaji median |
|---|---|---|
| Scientist, Medicinal Chemistry | 8 | $93,615 |
| Sr. Scientist, Product Development-Late Stage | 4 | $116,300 |
| Sr. Scientist – In Vitro Pharmacology | 2 | $125,000 |
| Principal Drug Safety Scientist | 2 | $125,700 |
| Scientist, Product Development, Late Stage | 1 | $90,480 |
| Senior Data Management Manager | 1 | $150,654 |
| Scientist, Product Development Operations | 1 | $118,600 |
| Principal Scientist, Analytical Development | 1 | $122,000 |
| Scientist, Chemical Development | 1 | $110,000 |
| Scientist, Antibody Engineering | 1 | $86,200 |
| Scientist, Biologics Research | 1 | $86,200 |
| Analyst, Systems | 1 | $86,200 |
| Senior Principal Scientist, Computational Chemistry | 1 | $150,700 |
| Senior Commercial Analytics Manager | 1 | $156,811 |
| Scientist, Biologics Lead Optimization | 1 | $112,000 |
| Senior Scientist, Analytical Development | 1 | $123,864 |
| Principal Analyst, Biopharmaceutical Statistical Programming | 1 | $146,224 |
| Manager, HEOR (Health Economics and Outcomes Research) | 1 | $135,720 |
| Senior Scientist, Analytical Development Stability | 1 | $108,701 |
| Scientist, Product Development | 1 | $88,130 |
| Sr. Scientist, Chemical Development | 1 | $124,654 |
| Senior Specialist, Analytical Development Stability | 1 | $108,701 |
| Principal Analyst, Statistical Programming | 1 | $141,856 |
| Principal Biostatistician | 1 | $141,856 |
| Sr. Patent Specialist | 1 | $136,300 |
| Sr. Specialist, R&D Strategic Operations | 1 | $116,355 |
| Senior Program Manager – Drug Development | 1 | $154,900 |
| Sr. Medical Director, MD | 1 | $301,100 |
| Sr. Scientist, Peptide/Bio-organic Chemistry | 1 | $121,722 |
| Senior Scientist, Product Development – Late Stage | 1 | $116,355 |
| Sr. Scientist, Neuroimmunology | 1 | $125,507 |
| Sr. Commercial Analytics Manager, Omnichannel | 1 | $158,100 |
| Sr. Scientist, Peptide Chemistry | 1 | $121,722 |
| Principal Scientist, Neuroimmunology | 1 | $130,800 |
| Sr. Data Management Manager | 1 | $180,502 |
| Sr. Analyst Financial | 1 | $113,880 |
Permohonan mengikut tahun fiskal
| Tahun fiskal | LCA | Gaji median |
|---|---|---|
| FY2023 | 8 | $107,675 |
| FY2024 | 9 | $112,000 |
| FY2025 | 15 | $124,259 |
| FY2026 | 16 | $121,722 |
Tahap gaji lazim
- Tahap I (permulaan)6%
- Tahap II (berkelayakan)21%
- Tahap III (berpengalaman)38%
- Tahap IV (kompeten sepenuhnya)35%
Jabatan Buruh menetapkan empat tahap gaji lazim untuk setiap pekerjaan dan kawasan, dari Tahap I (permulaan) hingga Tahap IV (cekap sepenuhnya). Majikan memilih tahap yang sepadan dengan keperluan jawatan.
Lokasi pekerjaan
Pekerjaan
- Biochemists and Biophysicists13
- Chemists12
- Medical Scientists, Except Epidemiologists7
- Regulatory Affairs Specialists3
- Statisticians3
- Management Analysts2
- Chemical Engineers2
- Computer Systems Analysts1
- Data Scientists1
- Regulatory Affairs Managers1
Permohonan terkini
| Jawatan | Gaji asas | Lokasi | Dihantar | Tarikh mula | Status |
|---|---|---|---|---|---|
| Sr. Analyst Financial | $113,880–$155,500 Tahap III | San Diego, CA | 17 Jun 2026 | 1 Okt 2026 | Disahkan |
| Sr. Data Management Manager | $180,502–$252,800 Tahap IV | San Diego, CA | 26 Mei 2026 | 15 Jun 2026 | Disahkan |
| Principal Scientist, Neuroimmunology | $130,800–$179,000 Tahap III | San Diego, CA | 21 Mei 2026 | 1 Okt 2026 | Disahkan |
| Sr. Scientist, Peptide Chemistry | $121,722–$177,400 Tahap IV | San Diego, CA | 5 Mei 2026 | 1 Okt 2026 | Disahkan |
| Scientist, Medicinal Chemistry | $102,482–$143,600 Tahap III | San Diego, CA | 4 Mei 2026 | 1 Okt 2026 | Disahkan |
| Scientist, Medicinal Chemistry | $102,482–$143,600 Tahap III | San Diego, CA | 4 Mei 2026 | 1 Okt 2026 | Disahkan |
| Sr. Scientist, Neuroimmunology | $125,507–$177,400 Tahap III | San Diego, CA | 4 Mei 2026 | 1 Okt 2026 | Disahkan |
| Sr. Commercial Analytics Manager, Omnichannel | $158,100–$252,800 Tahap IV | San Diego, CA | 4 Mei 2026 | 15 Mei 2026 | Disahkan |
| Senior Scientist, Product Development – Late Stage | $116,355–$177,400 Tahap III | San Diego, CA | 14 Apr 2026 | 1 Okt 2026 | Disahkan |
| Sr. Scientist, Peptide/Bio-organic Chemistry | $121,722–$177,400 Tahap IV | San Diego, CA | 13 Apr 2026 | 1 Okt 2026 | Disahkan |
| Sr. Medical Director, MD | $301,100–$481,000 Tahap IV | San Diego, CA | 13 Apr 2026 | 1 Okt 2026 | Disahkan |
| Senior Program Manager – Drug Development | $154,900–$247,700 Tahap IV | San Diego, CA | 5 Dis 2025 | 2 Jan 2026 | Disahkan |
| Sr. Scientist, Product Development-Late Stage | $108,600–$173,800 Tahap III | San Diego, CA | 2 Dis 2025 | 2 Jan 2026 | Disahkan |
| Sr. Scientist, Product Development-Late Stage | $108,600–$157,350 Tahap III | San Diego, CA | 18 Nov 2025 | 1 Dis 2025 | Disahkan |
| Principal Analyst, Statistical Programming | $141,856–$205,200 Tahap IV | San Diego, CA | 19 Ogo 2025 | 1 Sep 2025 | Disahkan |
| Principal Biostatistician | $141,856–$205,200 Tahap IV | San Diego, CA | 24 Jul 2025 | 28 Jul 2025 | Disahkan, kemudian ditarik balik |
| Sr. Patent Specialist | $136,300–$217,900 Tahap III | San Diego, CA | 22 Jul 2025 | 4 Ogo 2025 | Disahkan |
| Sr. Specialist, R&D Strategic Operations | $116,355–$161,700 Tahap III | San Diego, CA | 21 Jul 2025 | 21 Jul 2025 | Disahkan |
| Sr. Scientist, Chemical Development | $124,654–$173,800 Tahap III | San Diego, CA | 23 Jun 2025 | 30 Jun 2025 | Disahkan |
| Scientist, Medicinal Chemistry | $88,130–$140,800 Tahap II | San Diego, CA | 5 Mei 2025 | 1 Okt 2025 | Disahkan |
| Senior Specialist, Analytical Development Stability | $108,701–$152,400 Tahap III | San Diego, CA | 26 Mac 2025 | 5 Ogo 2025 | Disahkan |
| Scientist, Product Development | $88,130–$140,800 Tahap II | San Diego, CA | 5 Mac 2025 | 11 Jul 2025 | Disahkan |
| Senior Scientist, Analytical Development Stability | $108,701–$152,400 Tahap III | San Diego, CA | 14 Feb 2025 | 5 Ogo 2025 | Disahkan, kemudian ditarik balik |
| Senior Scientist, Analytical Development | $123,864–$170,300 Tahap III | San Diego, CA | 18 Dis 2024 | 17 Feb 2025 | Disahkan |
| Principal Drug Safety Scientist | $125,700–$201,100 Tahap IV | San Diego, CA | 16 Dis 2024 | 6 Jan 2025 | Disahkan |
| Principal Drug Safety Scientist | $125,700–$201,100 Tahap IV | San Diego, CA | 16 Dis 2024 | 6 Jan 2025 | Ditarik balik |
| Principal Analyst, Biopharmaceutical Statistical Programming | $146,224–$201,100 Tahap IV | San Diego, CA | 22 Nov 2024 | 2 Dis 2024 | Disahkan |
| Manager, HEOR (Health Economics and Outcomes Research) | $135,720–$182,250 Tahap II | San Diego, CA | 8 Okt 2024 | 15 Okt 2024 | Disahkan |
| Senior Commercial Analytics Manager | $156,811–$220,850 Tahap IV | San Diego, CA | 21 Ogo 2024 | 15 Sep 2024 | Disahkan, kemudian ditarik balik |
| Scientist, Biologics Lead Optimization | $112,000–$138,000 Tahap II | San Diego, CA | 12 Ogo 2024 | 1 Sep 2024 | Disahkan |
| Scientist, Antibody Engineering | $86,200–$138,000 Tahap I | San Diego, CA | 22 Apr 2024 | 1 Okt 2024 | Disahkan, kemudian ditarik balik |
| Scientist, Medicinal Chemistry | $100,859–$138,000 Tahap II | San Diego, CA | 22 Apr 2024 | 1 Okt 2024 | Disahkan |
| Scientist, Biologics Research | $86,200–$138,000 Tahap I | San Diego, CA | 22 Apr 2024 | 1 Okt 2024 | Disahkan |
| Analyst, Systems | $86,200–$138,000 Tahap I | San Diego, CA | 18 Apr 2024 | 1 Okt 2024 | Disahkan, kemudian ditarik balik |
| Senior Principal Scientist, Computational Chemistry | $150,700–$241,100 Tahap IV | San Diego, CA | 17 Apr 2024 | 1 Okt 2024 | Disahkan |
| Sr. Scientist, Product Development-Late Stage | $124,000–$170,300 Tahap III | San Diego, CA | 13 Mac 2024 | 15 Jul 2024 | Disahkan |
| Sr. Scientist, Product Development-Late Stage | $124,000–$170,300 Tahap III | San Diego, CA | 28 Feb 2024 | 19 Jul 2024 | Disahkan |
| Scientist, Chemical Development | $110,000–$138,000 Tahap III | San Diego, CA | 15 Feb 2024 | 26 Jul 2024 | Disahkan |
| Principal Scientist, Analytical Development | $122,000–$195,000 Tahap IV | San Diego, CA | 27 Nov 2023 | 8 Jan 2024 | Disahkan |
| Senior Data Management Manager | $150,654–$235,700 Tahap IV | San Diego, CA | 20 Sep 2023 | 20 Nov 2023 | Disahkan |
| Scientist, Product Development Operations | $118,600–$165,200 Tahap III | San Diego, CA | 23 Ogo 2023 | 22 Feb 2024 | Disahkan |
| Scientist, Medicinal Chemistry | $90,480–$134,700 Tahap II | San Diego, CA | 4 Mei 2023 | 1 Okt 2023 | Disahkan |
| Scientist, Medicinal Chemistry | $90,480–$134,700 Tahap II | San Diego, CA | 4 Mei 2023 | 1 Okt 2023 | Disahkan |
| Scientist, Medicinal Chemistry | $90,480–$134,700 Tahap II | San Diego, CA | 4 Mei 2023 | 1 Okt 2023 | Disahkan, kemudian ditarik balik |
| Scientist, Product Development, Late Stage | $90,480–$134,700 Tahap II | San Diego, CA | 4 Mei 2023 | 1 Okt 2023 | Disahkan |
| Scientist, Medicinal Chemistry | $96,750–$134,700 Tahap II | San Diego, CA | 3 Mac 2023 | 1 Mei 2023 | Disahkan |
| Sr. Scientist – In Vitro Pharmacology | $125,000–$136,000 Tahap IV | San Diego, CA | 12 Mei 2022 | 1 Okt 2022 | Disahkan, kemudian ditarik balik |
| Sr. Scientist – In Vitro Pharmacology | $125,000–$136,000 E-3 · Tahap IV | San Diego, CA | 17 Mac 2022 | 20 Mei 2022 | Disahkan, kemudian ditarik balik |
Gaji adalah bahagian bawah gaji yang ditawarkan dalam setiap permohonan, ditukar kepada jumlah tahunan; statistik hanya menggunakan permohonan sepenuh masa yang disahkan. LCA bukan kelulusan visa dan satu LCA boleh merangkumi beberapa jawatan. Sumber: Jabatan Buruh AS, Data Pendedahan LCA OFLC, tahun fiskal 2023–2026 (keputusan terkini 30 Jun 2026).